GAUTAM ELANGO EDHAYAN, MD, MSE

Plain English
This study looked at a serious case where a patient had a dangerous bleeding problem after a tooth extraction that couldn't be controlled by regular methods. Initially, doctors tried a technique called transradial coil embolization to stop the bleeding, but the patient later returned with another issue, a pseudoaneurysm, requiring further treatment. Ultimately, after a second attempt using a different embolization method, the patient's symptoms completely resolved. Who this helps: This helps patients experiencing severe dental bleeding issues.

Plain English
This study looked at a specific treatment method, called Onyx cast thrombectomy, for patients with a type of brain condition known as a thalamic arteriovenous malformation (AVM) that had ruptured. Researchers addressed complications that arose during the procedure, where the treatment material accidentally moved into a blood vessel, causing a blockage. They successfully used a technique to remove the unwanted material while still keeping the treatment on track, showing that this method can be effective in difficult situations. Who this helps: This benefits patients with ruptured thalamic AVMs and their doctors by offering a reliable solution during complicated treatments.

Plain English
This study looked at a new device called the Surpass Evolve (SE), which is used to treat specific brain aneurysms. Researchers found that 73% of aneurysms treated with SE completely closed after about 10 months, with a low rate of serious complications: only 2% of patients had major strokes and 0.7% died from the procedure. These findings show that the SE device is both effective and safe for treating these types of aneurysms. Who this helps: This helps patients with intracranial aneurysms and their doctors.

Plain English
This study looked at a serious complication—vessel perforation—occurring during a procedure called thrombectomy, which is used to remove blood clots from the brain. The researchers found that out of 459 patients with vessel perforations, 52% did not survive after 90 days, while only 16% had a good recovery. They determined that perforations in larger blood vessels led to worse outcomes, and the faster doctors could stop active bleeding, the better the chances of survival would be. Who this helps: This research benefits doctors performing thrombectomies and the patients undergoing the procedure.

Plain English
This study looked at the outcomes of carotid artery stenting (CAS) procedures done by specially trained neurointerventionalists at multiple stroke centers between 2018 and 2022. Out of 1,281 patients, only 1.8% experienced serious complications within 30 days, including 0.9% deaths and 0.55% strokes. This is noteworthy because it suggests that expert care in specialized centers can result in fewer complications compared to previous studies of similar procedures. Who this helps: This research benefits patients undergoing carotid artery stenting, particularly older adults and those with specific health conditions.

Plain English
This study looked at two ways to perform a procedure called extracranial carotid artery stenting, comparing the transradial (TR) method, which uses the wrist, to the traditional transfemoral (TF) method, which uses the thigh. It found that both methods had similar overall complication rates, but converting from TR to TF resulted in significantly higher risk of severe complications like stroke and heart attack, particularly when the angle from which the left common carotid artery branches is smaller than 90 degrees. Understanding these geometric factors can help doctors choose the safer approach for their patients. Who this helps: This helps patients undergoing carotid artery stenting and their doctors.

Plain English
This study looked at how well an artificial intelligence program called Viz ICH-Plus can automatically measure brain bleeding and shifts caused by pressure in patients with intracranial hemorrhage. The AI was tested on 78 scans from 30 patients, showing a small average error in its measurements—2.9 mL for bleeding volume, 5.3 mL for brain ventricle volume, and 1.1 mm for midline shift. The AI accurately detected significant changes in conditions between scans, with overall accuracy rates around 92%. Who this helps: This benefits doctors treating patients with brain injuries by providing faster and more reliable measurements.

Plain English
This study looked at two different techniques used during carotid artery stenting to see which one leads to fewer complications. Researchers analyzed data from 1,355 patients and found that performing balloon angioplasty after inserting the stent (Post-SB) resulted in fewer complications compared to either doing it before the stent (Pre-SB) or using both methods together. This is important because it helps guide doctors on the safest approach for patients undergoing carotid artery stenting. Who this helps: Patients undergoing carotid artery stenting.

Plain English
This study looked at how effective the Surpass Evolve flow diverter is for treating patients with brain aneurysms that have been previously treated compared to those that have not. Out of 257 patients, those with previously treated aneurysms achieved complete blockage in 59.7% of cases, while 72.3% of untreated cases were successfully blocked. This is important because it helps doctors understand the potential outcomes for patients with a history of treatment, ensuring they choose the best approach for managing their aneurysms. Who this helps: This benefits patients with brain aneurysms, particularly those who have already undergone treatment.

Plain English
This study looked at the occurrence of blood vessel perforations during two types of procedures to remove clots from the brain: medium vessel occlusion (MeVO) and large vessel occlusion (LVO) thrombectomy. Out of nearly 26,000 procedures, perforations happened in about 1.3% of patients, with MeVO procedures showing a higher rate of 2.4% compared to 1.0% for LVO. Notably, 25.7% of MeVO patients who had a perforation were able to regain functional independence within three months, compared to just 10.9% of LVO patients, highlighting a noticeable difference in outcomes. Who this helps: This information is valuable for doctors and patients undergoing thrombectomy for stroke treatment.

Plain English
This study looked at how a new imaging tool called microangioscopy can help doctors see how well a type of stent, used to manage brain aneurysms, integrates into blood vessels after it's placed. Researchers tested two types of stents in rabbits and found that those who received no medication had more blood clots, while those on aspirin or a combination of aspirin and clopidogrel had fewer complications. The findings are important because they show that using microangioscopy can provide clear insights into stent performance, which may improve patient care in the future. Who this helps: This helps patients with brain aneurysms and the doctors treating them.

Plain English
This study examined the use of a new medical device, the 64-wire Surpass Evolve, to treat unruptured small and medium-wide necked brain aneurysms. The researchers found that 77.1% of the patients had complete closure of their aneurysms after treatment, with only 1.6% experiencing serious strokes and 0.8% dying as a result of the procedure. This means that the Surpass Evolve could be a safe and effective option for managing these types of aneurysms, which are at risk of causing serious health problems if left untreated. Who this helps: This benefits patients with unruptured brain aneurysms, particularly those with small to medium-sized ones.

Plain English
This study looked at how the origin of branches from intracranial aneurysms (IA) affects the success of a specific treatment using a flow diversion device called Surpass Evolve. Researchers found that when branches come from the neck of the aneurysm, the chance of completely closing off the aneurysm is higher (93%) compared to when branches come from the sac (61%). This is important because understanding these differences can lead to better treatment planning and potentially improved outcomes for patients. Who this helps: Patients with intracranial aneurysms.

Plain English
This study looked at a rare but serious complication called a cystic artery pseudoaneurysm that can occur after a specific liver biopsy procedure in a 52-year-old man with liver disease. After the biopsy, he experienced heavy bleeding and was found to have a pseudoaneurysm, which was successfully treated with a minimally invasive procedure called embolization, allowing him to recover well. This matters because it raises awareness among doctors about this uncommon issue that can lead to serious problems after liver biopsies. Who this helps: This helps doctors and healthcare providers managing patients undergoing liver biopsies.

Plain English
This study looked at a new method for treating brain blood vessel problems when traditional approaches are difficult or impossible. Researchers found that out of 273 cases where this "transcirculation" method was used, it was effective for treating conditions like brain aneurysms and strokes. This matters because it provides doctors with a safer and more effective option for patients who might not otherwise have successful treatment. Who this helps: Patients with complex brain blood vessel issues.

Plain English
This study looked at a 37-year-old man who had been experiencing abdominal pain and other symptoms due to a misplaced catheter from a device he had for controlling fluid in his brain. Medical imaging revealed that the catheter tip was located in his small intestine instead of where it should be, which was confirmed by surgery. This finding is important because it shows how imaging can help detect complications from medical devices, ensuring patients receive the right treatment quickly. Who this helps: This helps patients with ventriculoperitoneal shunts and their doctors.

Plain English
This study examined a new computer program designed to detect and analyze brain aneurysms using imaging scans. Researchers tested the program on 400 patients and found that it correctly identified brain aneurysms 93.8% of the time and was very accurate in measuring their size and location. This is important because it could improve the diagnosis of brain aneurysms, leading to better patient care. Who this helps: Patients at risk of cerebral aneurysms.

Plain English
This study examined how flow cytometry, a laboratory technique, can help diagnose tumors in the spleen when traditional methods may not provide enough information. In a specific case, flow cytometry suggested that a splenic lesion was a neuroendocrine tumor, which was later confirmed. This approach can speed up the diagnosis of rare tumors in the spleen, allowing for more accurate testing even with limited samples. Who this helps: This benefits patients with rare splenic tumors and the doctors treating them.

Plain English
This study looked at a new method for treating strokes called the SOFIA Nonwire Advancement techniKE 35 (SNAKE35), which uses a special catheter to access blocked blood vessels in the brain. In a group of 140 stroke patients, the SNAKE35 method successfully placed the catheter at the blockage in 66 out of 79 attempts (84%). Additionally, this technique reduced the average time to restore blood flow to about 26 minutes, compared to 37 minutes with traditional methods, which is important for better patient outcomes. Who this helps: This benefits stroke patients by enabling quicker treatment during critical moments.

Plain English
Researchers found that a protein called ID-1 becomes modified in rheumatoid arthritis patients' joints in a way that triggers the immune system to attack it—this modification doesn't happen in healthy people. When they removed ID-1 from arthritis cells in the lab, the cells produced more inflammatory chemicals and grew less, suggesting ID-1 normally helps control inflammation in the joint. ID-1 levels in patients' blood dropped after they received anti-inflammatory treatment, and three specific spots on the protein are responsible for triggering the immune attack. **Why it matters:** This discovery identifies a new target that the immune system mistakenly attacks in rheumatoid arthritis, which could help explain why the disease develops and might lead to better treatments or diagnostic tests.

Plain English
This study looked at whether acupressure could help people with Raynaud's phenomenon, a condition that affects blood flow to the extremities, causing coldness and discomfort. Researchers found that both acupressure and patient education led to similar decreases in the frequency and duration of symptoms, with 6.7 attacks per week in the acupressure group and 7.2 in the education group, showing no significant improvement from acupressure. This matters because it suggests that acupressure may not provide additional benefits for patients with Raynaud's phenomenon compared to education alone. Who this helps: Patients with Raynaud's phenomenon and their doctors.

Plain English
This study focused on a protein called Id1 produced by specific cells in the joints of people with rheumatoid arthritis (RA). Researchers discovered that activated fibroblasts in the joints are the primary source of Id1, which is linked to higher levels of inflammation. They found that Id1 not only affects blood vessel formation but is also released from these cells in tiny packages called exosomes, showing it plays a key role in the inflammation process. Who this helps: This benefits patients with rheumatoid arthritis by providing insights that could lead to new treatment strategies.

Plain English
This study looked at how a compound called 8-isoprostane affects blood vessel growth in patients with scleroderma, a condition that causes the skin and connective tissues to tighten and harden. Researchers found that higher levels of 8-isoprostane in patients inhibited the normal blood vessel growth process triggered by a protein called VEGF. Specifically, in lab tests, adding vitamin E, which reduces 8-isoprostane, helped restore this blood vessel growth, indicating that targeting this pathway could be important for improving treatment for scleroderma. Who this helps: This helps patients with scleroderma.

Plain English
This study looked at how a protein called Fut1 affects blood vessel growth (angiogenesis) and inflammation in a type of arthritis known as K/BxN arthritis. The researchers found that mice lacking Fut1 had less blood vessel growth and were resistant to arthritis symptoms compared to normal mice. Specifically, these Fut1-deficient mice showed a 50% reduction in angiogenesis and significantly less immune cell activity in their inflamed joints. Who this helps: This research benefits patients with rheumatoid arthritis by identifying potential targets for treatment.

Plain English
This study looked at a protein called CD13 that is produced by certain cells in the joints of people with rheumatoid arthritis (RA) to see if it helps attract immune cells called T cells to the affected areas. Researchers found that CD13 levels were significantly higher in the joint fluid of RA patients compared to those with osteoarthritis and that CD13 helps T cells move toward the joints independently of its enzymatic function. This is important because it suggests that targeting CD13 could help manage the inflammation and pain associated with RA. Who this helps: This helps patients with rheumatoid arthritis.

Plain English
This study looked at how the timing of radiation therapy after a mastectomy affects complications in women getting breast implants. Researchers examined 54 patients and found that whether women received radiation before or after getting their permanent implants made no difference in complications like infections or implant loss. This is important because it helps doctors make clearer decisions about the timing of radiation for breast reconstruction without worrying about increasing risks of complications. Who this helps: This helps patients who are considering implant-based breast reconstruction after a mastectomy.

Plain English
This study examined the role of an enzyme called fucosyltransferase 1 (fut1) in the tissue of patients with rheumatoid arthritis (RA). The researchers found that levels of certain fucosylated proteins were significantly higher in RA tissue than in normal tissue, and that reducing fut1 activity decreased blood vessel formation and the growth of cells involved in RA. This matters because it shows how fut1 contributes to the worsening of RA symptoms, highlighting a potential target for new treatments. Who this helps: Patients with rheumatoid arthritis.

Plain English
This research focused on a protein called Inhibitor of DNA Binding 1 (Id1) and its role in promoting the growth of new blood vessels in the joints of people with rheumatoid arthritis (RA). The study found that Id1 levels were significantly higher in the joint fluid and tissues of RA patients compared to those with osteoarthritis or normal joints, with a notable increase in blood vessel formation when influenced by Id1. This is important because it highlights a potential target for treatments aimed at reducing the excessive blood vessel development associated with RA, potentially alleviating symptoms and slowing disease progression. Who this helps: This helps patients with rheumatoid arthritis.